1. Home
  2. VSAT vs BLCO Comparison

VSAT vs BLCO Comparison

Compare VSAT & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ViaSat Inc.

VSAT

ViaSat Inc.

HOLD

Current Price

$46.59

Market Cap

5.6B

Sector

Technology

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$15.38

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VSAT
BLCO
Founded
1986
1853
Country
United States
Canada
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Ophthalmic Goods
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
6.0B
IPO Year
1996
2022

Fundamental Metrics

Financial Performance
Metric
VSAT
BLCO
Price
$46.59
$15.38
Analyst Decision
Buy
Buy
Analyst Count
6
12
Target Price
$46.20
$18.55
AVG Volume (30 Days)
1.4M
380.7K
Earning Date
02-05-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
50.88
N/A
EPS
N/A
N/A
Revenue
N/A
$5,101,000,000.00
Revenue This Year
$5.34
$8.63
Revenue Next Year
$3.59
$5.58
P/E Ratio
N/A
N/A
Revenue Growth
N/A
6.47
52 Week Low
$7.36
$10.45
52 Week High
$52.70
$18.92

Technical Indicators

Market Signals
Indicator
VSAT
BLCO
Relative Strength Index (RSI) 48.64 34.23
Support Level $41.76 $14.39
Resistance Level $50.53 $17.66
Average True Range (ATR) 3.20 0.49
MACD -0.18 -0.12
Stochastic Oscillator 21.04 1.16

Price Performance

Historical Comparison
VSAT
BLCO

About VSAT ViaSat Inc.

Viasat Inc provides bandwidth technologies and services in three segments: communication services and defense and advanced technologies. The communication services segment provides a wide range of broadband and narrowband communications solutions across government and commercial mobility markets, as well as for residential and enterprise fixed broadband customers: and the defense and advanced technologies segment develops and offers a diverse array of resilient, vertically integrated solutions to government and commercial customers, leveraging core technical competencies in encryption, cyber security, tactical gateways, modems and waveforms. A large majority of the firm's revenue is generated from communication services segment.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: